Li, Xinxiu
Lee, Eun Jung
Lilja, Sandra
Loscalzo, Joseph
Schäfer, Samuel
Smelik, Martin
Strobl, Maria Regina
Sysoev, Oleg
Wang, Hui
Zhang, Huan
Zhao, Yelin
Gawel, Danuta R.
Bohle, Barbara
Benson, Mikael https://orcid.org/0000-0002-7753-9181
Funding for this research was provided by:
National Institutes of Health (HG007690,HL108630, HL155107, HL155096, and HL119145)
American Heart Association (D700382)
VINNOVA (90825)
European Commission (848028≠2)
Swedish Cancer Society (CAN 2017/411)
Joanna Cocozza Foundation
National Research Foundation of Korea (NRF) grant funded by the Korea government (2021R1A2C101008211)
Austrian Science Funds (P32953, I4437)
Vetenskapsrådet (2019-01165)
Linköping University
Article History
Received: 21 December 2021
Accepted: 13 April 2022
First Online: 6 May 2022
Declarations
:
: The human studies were approved by the Linköping University Hospital Institutional Review Board and Medical University of Vienna. Written informed consent was obtained from all participants to participate in the study. This study was conducted in accordance with the Declaration of Helsinki.
: Not appliable
: MB is scientific founder of Mavatar, Inc. JL is co-scientific founder of Scipher Medicine, Inc. The other authors declare that they have no competing interests.